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Abstract
Background: The nuclear factor-KappaB (NF-B) pathway is conserved from fruit flies to humans and is a key
mediator of inflammatory signaling. Aberrant regulation of NF-B is associated with several disorders including
autoimmune disease, chronic inflammation, and cancer, making the NF-B pathway an attractive therapeutic
target. Many regulatory components of the NF-B pathway have been identified, including microRNAs (miRNAs).
miRNAs are small non-coding RNAs and are common components of signal transduction pathways. Here we
present a cell-based functional genomics screen to systematically identify miRNAs that regulate NF-B signaling.
Results: We screened a library of miRNA mimics using a NF-B reporter cell line in the presence and absence of
tumor necrosis factor (+/- TNF). There were 9 and 15 hits in the -TNF and +TNF screens, respectively. We identified
putative functional targets of these hits by integrating computational predictions with NF-B modulators identified
in a previous genome-wide cDNA screen. miR-517a and miR-517c were the top hits, activating the reporter 86-
and 126-fold, respectively. Consistent with these results, miR-517a/c induced the expression of endogenous NF-B
targets and promoted the nuclear localization of p65 and the degradation of IB. We identified TNFAIP3
interacting protein1 (TNIP1) as a target and characterized a functional SNP in the miR-517a/c binding site. Lastly,
miR-517a/c induced apoptosis in vitro, which was phenocopied by knockdown of TNIP1.
Conclusions: Our study suggests that miRNAs are common components of NF-B signaling and miR-517a/c may
play an important role in linking NF-B signaling with cell survival through TNIP1.
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Background
Nuclear factor kappa-B (NF-B) is well conserved, ubi-
quitously expressed, and a pivotal regulator of immune
response, inflammation and cell survival [1-3]. Dysregu-
lation of NF-B signaling is associated with numerous
human diseases ranging from cancer to Crohn’s disease
[4], underscoring the role of NF-B in physiological
processes. Since the discovery of NF-B twenty-six years
ago [5,6], much insight has been gained into the regula-
tion of its signaling and many pathway components
have been characterized [7].
The NF-B transcription factor is a dimer composed of
structurally related Rel family proteins [7]. Of these, the
p50-p65 NF-B heterodimer is best characterized. The
cytokine tumor necrosis factor (TNF) is a strong inducer
of p50-p65/NF-B signaling [7,8]. Upon binding to cell
surface receptors, TNF initiates a signaling cascade result-
ing in the phosphorylation of I-kappaB (IB) kinase (IKK)
-a large cytoplasmic multi-protein complex [7,9]. IKK in
turn phosphorylates IB-a bound to NF-B. This results
in proteasomal degradation of IB-a, freeing NF-B to
translocate into the nucleus and activate its targets [7].
Many of these targets include activators (for example,
TNF, IL6) and inhibitors (for example, IB-a, A20, tumor
necrosis factor alpha-induced protein 3 interacting protein
1 (TNIP1)) of NF-B signaling, hence providing context
specific feedback regulation.
MicroRNAs (miRNAs) are a class of small non-coding
RNAs (ncRNAs) that bind to target mRNAs and pro-
mote transcript degradation and/or inhibit translation
[10]. Studies suggest that miRNAs are common compo-
nents of signal transduction pathways, conferring
robustness to gene expression and feedback to cellular
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networks [11-13]. Several miRNAs are known to regu-
late NF-B signaling [14]. The earliest example is miR-
146, an inhibitor of toll-like receptor (TLR) mediated
NF-B signaling [15]. Another example, the miR-125
family, promotes NF-B signaling by targeting TNF
alpha-induced protein 3 (TNFAIP3), an inhibitor of
NF-B signaling [16]. Further exemplifying the
complexity of regulation, miR-21 promotes NF-B sig-
naling via the PTEN/AKT pathway in MCF-10A cells
[17] but inhibits lipopolysacharride (LPS) mediated
NF-B signaling in TLR4 expressing HEK293 cells
[18]. In the above examples, the miRNAs are them-
selves direct (miR-146, miR-125ab) or indirect (miR-21)
targets of NF-B, suggesting that feedback regulation is
common [15,17,19].
In this study, we sought to systematically characterize
the role of miRNAs in NF-B signaling using high-
throughput cell based screening. We confirmed previously
known regulators and identified novel candidates. Further,
we derived likely targets for these hits by incorporating
other high-throughput/computational datasets. Lastly, we
characterized the top hits, miR-517a/c, identified their
target, and explored the relationship between their impact
on NF-B signaling and their regulation of apoptosis in
the human embryonic kidney cell line HEK293 and the
osteosarcoma cell line U-2 OS.
Results
Genome-wide miRNA screen identifies regulators of
NF-B signaling
To identify miRNAs involved in the regulation of NF-B
signaling, we transfected HEK293 cells stably expressing a
NF-B responsive luciferase reporter (NF-B-luc cells)
with a library of 328 miRNA mimics (miRBase v8.0; see
Additional file 1, Table S1 for annotation) in duplicate
(Figure 1A). Seventy-two hours post-transfection, the cells
were treated with TNF (+TNF) or vehicle control (-TNF)
for 8.5 hours. Luminescence was then measured from
each well (Figure 1A; Additional file 1, Table S2). Boxplots
of the luminescence values for each screen are shown in
Figure 1B. The addition of TNF to the cells induced the
average plate-wide reporter activity approximately 400-
fold (Figure 1B). Z-scores were calculated from the lumi-
nescence values (see methods) and were highly replicable
for the -TNF (r = 0.73) and +TNF (r = 0.98) screens
(Figure 1C). Hits from the screens were those miRNAs
that differentially regulated the reporter (up or down) rela-
tive to the plate median. At a P-value cutoff of 0.02 there
were 9 (false discovery rate (FDR) = 18%) and 15 (FDR =
12%) hits in the -TNF and + TNF screens, respectively
(Wilcoxon rank-sum test; Table 1). Two of these, miR-483
and miR-452*, were hits in both screens.
Putative functional targets of miRNAs derived from
overlap of prediction data and genome-wide cDNA screen
In a previous genome-wide cDNA screen for regulators
of NF-B signaling, we identified 154 activators and 88
repressors [20]. To identify functional targets of the
miRNA hits in our screen, we compared regulators from
the cDNA screen with predicted miRNA targets. The
predictions were generated with code from TargetScan
6.0 [21,22]. For miRNAs that activated signaling in our
screen, we took the intersection of predicted targets and
negative regulators from the cDNA screen (Figure 2A).
Conversely, for miRNAs that repressed signaling, we
took the overlap between predicted targets and activators
from the cDNA screen (Figure 2B). We obtained several
candidate genes for each of the miRNAs with the excep-
tion of miR-517a/c (Figure 2C). This was due in part to
the smaller number of total predicted targets for miR-
517a/c compared to the other miRNAs (see Additional
file 1, Table S3). To obtain high confidence functional
targets for each of the miRNAs, we set a cutoff of two
median absolute deviations (mad) from the median
prediction score of all miRNA-mRNA interactions
(Figure 2C). The prediction score, or context score (CS),
is the sum of multiple feature scores characterizing the
proposed miRNA-mRNA interaction [21]. The more
negative the CS, the more favorable the predicted inter-
action. The resulting miRNAs and their targets are listed
in Table 2. Five of the 8 miRNA repressors and 7 of the
13 miRNA activators had one or more predicted targets
meeting the cutoff. miR-124 and miR-506 were particu-
larly noteworthy. They both repressed NF-B signaling
in our screen and were predicted to target RELA/p65, a
core pathway component and a positive regulator in the
cDNA screen (Table 2). Also, miR-452*, an activator in
our screen, was predicted to target NFKBIE, a repressor
of NF-B signaling. Hence, these results suggest that the
integration of data from genome-wide cDNA screens and
computational target predictions may help in identifying
functional miRNA targets.
Secondary screen confirms top hits
Next, we selected representative miRNAs for secondary
screening: those that activated the reporter in the -TNF
screen (miR-517a, miR-517c), inhibited the reporter in the
+TNF screen (miR-210, miR-375), or activated the repor-
ter in both screens (miR-483). The miR-517 family
consists of three highly homologous members, miR-517a,
miR-517b, and miR-517c, yet intriguingly, miR-517b, was
not a hit in the primary screen. Nonetheless, we included
miR-517b in the secondary screen to eliminate the possibi-
lity that it was a false-negative. In the secondary screen,
the miRNAs were co-transfected with a constitutively
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expressed Renilla reporter plasmid. This served as a con-
trol for transfection efficiency and background effects
caused by the miRNAs. Corroborating the primary screen
results, miR-517a and miR-517c were potent activators
(59- and 38-fold, respectively) of the reporter in the
absence of TNF, but did not potentiate TNF induced
reporter activity (Figure 3, A and B). In fact, there was a
small but significant (P = 0.01) reduction in reporter activ-
ity in the miR-517c transfected cells stimulated with TNF.
Overexpression of miR-517b caused a relatively small
increase in reporter activity (2.6-fold) and hence, was
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Figure 1 Genome-wide miRNA screen for regulators of NF-B signaling. (A) Primary screen schematic. HEK293 cells stably expressing a NF-
B-luc reporter were transfected with a library of miRNA mimics. Plates were incubated under normal growth conditions for 72 hours. Cells
were then treated with vehicle control or TNF for 8.5 hours. Luminescence was read from each well. (B) Boxplots of luminescence values for the
-TNF and +TNF screens. (C) Replicate analysis for each screen (-/+TNF) with luminescence values converted to Z-scores. NF-B, nuclear factor
kappa-B; NF-B-luc, NF-B responsive luciferase reporter; TNF, tumor necrosis factor.
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miR-375 overexpression significantly inhibited TNF
induced reporter activity by 8.1- and 14.3-fold (P ≤0.005,
Figure 3B), respectively. Surprisingly, miR-210 induced
basal reporter activity by 6.4-fold (Figure 3A; P = 0.02).
Lastly, miR-483 potentiated signaling in both the -TNF
(36-fold, P = 0.004) and +TNF (3.5-fold, P = 0.007) condi-
tions relative to the respective negative controls (Figure 3,
A and B). In all, the hits from our initial screen were vali-
dated in the secondary screen.
Effect of miR-517 family on endogenous NF-B targets
and signaling components
We decided to follow up on the miR-517 family with addi-
tional experiments for several reasons: 1) miRNAs typically
have a moderate impact on their targets yet miR-517a/c
were potent activators of reporter activity in the absence of
any added stimulus; 2) we were intrigued that miR-517b
did not activate signaling despite extensive sequence simi-
larity to miR-517a/c; and 3) a previous proteomics study
by Luo et al. suggested miR-517a involvement in MAPK
and TNF signaling in BeWo cells [23].
The miR-517 family is located in a large, primate-specific
miRNA cluster on human chromosome 19 (C19MC) [24].
The miR-517 miRNAs share extensive sequence homol-
ogy. miR-517a and miR-517c differ by one nucleotide at
position 12, and miR-517b is shifted by one nucleotide
relative to miR-517a (Figure 4A). This shift in miR-517b
also results in a shifted seed sequence (Figure 4A). The
seed sequence of the miRNA (nucleotides 2 to 8) is a
primary determinant of functional interaction between a
miRNA and its target. Hence, the shift in the miR-517b
seed likely alters target interaction relative to miR-517a/c.
Nonetheless, it was unexpected to see such a large
difference between miR-517a/c and miR-517b in our
reporter assays.
Next, we wanted to test the effect of the miR-517 miR-
NAs on endogenous NF-B targets. We transfected
HEK293 cells with the miR-517 mimics and measured the
expression of IL8 and TNF mRNA in unstimulated cells
(Figure 4B) and in cells stimulated with TNF for three
hours (Figure 4C). In unstimulated cells, miR-517a/c
strongly induced IL8 (>160-fold) and TNF (>40-fold)
expression while miR-517b had only a modest effect (13-
and 4-fold, respectively), confirming the reporter results
(Figure 3A). However, in cells treated with TNF, there was
no significant change in IL8 and TNF expression in cells
transfected with the miR-517 mimics relative to the nega-
tive control (Figure 4C). To verify that miR-517a/c were
acting through the NF-B pathway, we co-transfected the
mimics with one of two independent small interfering
RNAs (siRNAs) against the p65 subunit of NF-B (efficacy
of the siRNAs is demonstrated in Additional file 2,
Figure S1). Both siRNAs reduced miR-517a/c induced
expression of IL8 and TNF at least 6-fold (Figure 4D;
P ≤0.01). Lastly, the nuclear translocation of p65 and the
proteasomal degradation of IB-a are indicative of NF-B
activation. Hence, we evaluated the effect of miR-517a/c
on the subcellular localization and expression of p65 and
IB-a in HEK293 cells. miR-517a/c, but not miR-517b,
increased nuclear p65 and decreased cytoplasmic IB-a
expression relative to the negative control (Figure 4D).
Further, there was increased NF-B DNA binding activity
in the nuclear extracts of cells transfected with miR-517a
and miR-517c, but not miR-517b as measured with ELISA
(Active Motif TransAM p65 NF-B assay; Figure 4F). In
all, these results confirmed the primary and secondary
screen data that miR-517a/c, and not miR-517b, were
potent activators of NF-B signaling.
To confirm that the effects of miR-517a/c on NF-B
signaling were not restricted to HEK293 cells, we also
tested primary human umbilical vein endothelial cells
(HUVECs). Similarly, miR-517a/c increased target gene
expression (IL8, IL6 and TNF) in a p65-dependent man-
ner and increased p65 nuclear translocation (see
Additional file 2, Figure S2).
Table 1 Top hits in -TNF and +TNF screens.
-TNF screen
miRNA Seed sequence Fold change Z-score P-value
hsa-miR-517c UCGUGCA 126.3 4.8 0.015
hsa-miR-517a UCGUGCA 86.2 4.4 0.015
hsa-miR-544 UUCUGCA 37.9 3.6 0.016
hsa-miR-337 CCAGCUC 38.0 3.6 0.016
hsa-miR-452* CAGUCUC 19.7 3.0 0.018
hsa-miR-326 CUCUGGG 18.8 2.9 0.018
hsa-miR-184 GGACGGA 19.0 2.8 0.019
hsa-miR-34b AGGCAGU 16.1 2.7 0.019
hsa-miR-483 CACUCCU 12.8 2.5 0.019
+TNF screen
miRNA Seed sequence Fold change Z-score P-value
hsa-miR-124a UAAGGCA -82.8 -4.6 0.015
hsa-miR-452* CAGUCUC 4.5 1.6 0.015
hsa-miR-483 CACUCCU 6.1 1.9 0.015
hsa-miR-506 AAGGCAC -22.8 -3.3 0.016
hsa-miR-345 GCUGACU -22.9 -3.3 0.016
hsa-miR-24 GGCUCAG -23.7 -3.3 0.016
hsa-miR-375 UUGUUCG -21.2 -3.2 0.016
hsa-miR-141 AACACUG 3.9 1.4 0.018
hsa-miR-130a AGUGCAA 3.8 1.4 0.018
hsa-miR-491 GUGGGGA -15.3 -2.9 0.018
hsa-miR-30a-3p UUUCAGU 3.9 1.4 0.018
hsa-miR-489 GUGACAU -13.7 -2.7 0.018
hsa-miR-125b CCCUGAG 3.5 1.3 0.020
hsa-miR-200b AAUACUG 3.8 1.4 0.020
hsa-miR-210 UGUGCGU -9.8 -2.4 0.020
miRNA, microRNA; TNF, tumor necrosis factor.
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Figure 2 Functional target identification for top miRNA hits. (A and B) Predicted miRNA targets were compared to NF-B signaling
modulators identified in a previous genome-wide cDNA screen. (A) miRNAs that repressed NF-B likely targeted activators of the pathway. (B)
Conversely, miRNAs that activated NF-B likely targeted repressors. (C) Scatterplot of the context scores of the predicted targets for each miRNA
hit from the screen. y-axis is the negated context score (a more negative context score indicates a more confident prediction). Colors are
alternated between black and grey for visual clarity. Solid black line is the median -context score for all miRNA-mRNA predictions (that is all 328
miRNAs and approximately 31,000 transcripts). Dashed line represents cutoff of 2 MAD from the median. MAD, median absolute deviations;
miRNA microRNA; NF-B, nuclear factor kappa-B.
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TNIP1 is a direct functional target of miR-517a/c
miRNAs function primarily by down-regulating the
expression of their targets. Therefore, we deduced the
likely target of miR-517a/c was an inhibitor of NF-B sig-
naling. We searched the TargetScan predictions for
known repressors. TNIP1, also known as A20-binding
inhibitor of NF-B activation (ABIN1), was one of the top
predicted targets. TNIP1 binds to TNFAIP3, a ubiquitin-
editing enzyme, and together they inhibit RIPK dependent
NF-B signaling [25,26]. A clone for the mouse Tnip1
gene was present in the cDNA library used for the analysis
in Figure 2; however, it did not pass the multiple stages of
filtering to be included in the final list of NF-B modula-
tors [20]. To test if TNIP1 was indeed a functional target
of miR-517a/c, we measured its protein levels in HEK293
cells transfected with the miRNA mimics. Both miR-517a
and miR-517c, but not miR-517b, potently reduced TNIP1
protein levels (Figure 5A). Next, we tested if siRNAs tar-
geting TNIP1 could phenocopy miR-517a/c. Indeed, two
independent siRNAs significantly increased endogenous
expression of IL8 and TNF in HEK293 cells (Figure 5B).
Finally, we hypothesized that overexpression of TNIP1
would block the effect of miR-517a/c. We tested this by
creating a TNIP1 cDNA construct with a truncated 3’UTR
lacking the miR-517a/c target site. This ensured that the
effects we saw were due to the activity of TNIP1 protein
and not due to competition for miR-517a/c binding.
Expression of TNIP1 from the construct was confirmed
via western blot (see Additional file 2, Figure S3). Co-
transfection of the TNIP1 construct with the miRNA
mimics reduced miR-517a/c-induced expression of IL8
and TNF in HEK293 cells (Figure 5C).
Next, we took a closer look at the genomic region
corresponding to the miR-517a/c binding site in TNIP1.
This revealed two interesting features. First, the target site
is poorly conserved, with notable differences in the
mouse and rat genomes (Figure 5D). Secondly, a SNP
(rs72558377) is located in the target site corresponding to
the third position of the miRNA seed (Figure 5E). The
minor allele (T) results in a G-U wobble base pair, possibly
affecting miRNA-target interaction (Figure 5E). To test the
functional consequence of this SNP as well as demonstrate
direct interaction between miR-517a/c and TNIP1, we
cloned sequences containing the major and minor alleles
Table 2 High confidence functional targets from miRNA predictions and genome-wide cDNA screen.
miRNAs repressing NF-B signaling
miRNA Gene Transcripts CS CSP
miR-24 MYD88 NM_001172569, NM_002468, NM_001172568, NM_001172567, NM_001172566 -0.319 95
RASL11B NM_023940 -0.35 96
RELA NM_021975, NM_001145138 -0.307 93
miR-124 TRIM22 NM_001199573, NM_006074 -0.339 96
BECN1 NM_003766 -0.339 96
miR-210 CCNL2 NM_001039577 -0.275 85
miR-491 PLEKHB1 NM_021200, NM_001130033, NM_001130035, NM_001130034, NM_001130036 -0.314 98
TULP3 NM_003324 -0.278 97
TNFSF10 NM_001190943 -0.336 99
miR-506 RELA NM_021975, NM_001145138 -0.401 98
miRNAs activating NF-B signaling
miRNA Gene Transcripts CS CSP
MATN2 NM_030583, NM_002380 -0.351 96
miR-30a GPR161 NM_153832 -0.298 93
PTGER2 NM_000956 -0.328 95
miR-34b TLR7 NM_016562 -0.356 98
miR-125b IKBKG NM_001099857, NM_001099856, NM_001145255 -0.297 92
MAP3K11 NM_002419 -0.337 95
miR-141 PTGDR NM_000953 -0.3 97
miR-184 TNK2 NM_001010938, NM_005781 -0.452 94
SLC7A5 NM_003486 -0.306 85
miR-452* LPAR2 NM_004720 -0.304 95
STMN1 NM_001145454 -0.367 98
NFKBIE NM_004556 -0.288 94
miR-544 TSPAN13 NM_014399 -0.279 92
CS, context score; CSP, context score percentile; miRNAs, microRNAs; NF-B, nuclear factor-kappa B. A more negative CS is associated with a more favorable
miRNA-mRNA interaction.
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immediately downstream of a firefly luciferase reporter.
The same plasmid also expressed Renilla luciferase from a
separate constitutive promoter, which was used as a con-
trol for transfection efficiency. miR-517a and miR-517c
repressed the reporter containing the major allele variant
but had no effect on the empty vector (Figure 5F). miR-
517b also inhibited reporter activity, but to a lesser extent
(Figure 5F). The repression by the miR-517 miRNAs was
significantly alleviated in the minor allele reporter (Figure
5F). These results suggested that miR-517a/c interact
directly with TNIP1 and that the minor allele of SNP
rs72558377 decreases miRNA-target interaction and con-
sequently miR-517a/c mediated repression of TNIP1.
Lastly, given that TNIP1 is a TNF regulated gene [27]
and miRNAs are common in feedback regulation, we
hypothesized that NF-B regulates miR-517a/c which in
turn activates the pathway through knockdown of
TNIP1. To test this we treated HEK293 cells with TNF
over time and measured expression of TNIP1 mRNA
and miR-517a/c. While there was a significant increase
in TNIP1 expression, miR-517a/c expression was not
significantly changed (see Additional file 2, Figure S4).
miR-517a/c induce apoptosis in HEK293 and U-2 OS cells
miR-517a/c activation has been shown to promote cell
survival and induce oncogenesis [28,29]. Surprisingly, we
observed extensive cell death in an immortalized cell
line, HEK293, and an osteosarcoma cell line, U-2 OS,
transfected with miR-517a/c (Figure 6A). We measured






























































































Figure 3 Secondary screen validation of top hits. NF-B -luc cells were co-transfected with the indicated miRNAs and a constitutively
expressed Renilla reporter plasmid. Firefly luciferase activity was normalized to that of Renilla luciferase. All values are means ± SD. n = 3. *P
≤0.05, **P ≤0.01. miRNAs, micro RNAs; NF-B, nuclear factor kappa-B; NF-B-luc, NF-B responsive luciferase reporter; SD, standard deviation.
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miR-517a:  a ucccuuuagaguguucgugca
miR-517b:    u cccuuuagaguguucgugcau

































































































































































Figure 4 Validation and characterization of miR-517a/c. (A) Sequence comparison of the miR-517 family miRNAs. Seed sequences
(nucleotides 2 to 8) are highlighted in red. (B and C) HEK293 cells were transfected with the indicated miRNA mimics for 72 hours. mRNA
expression of endogenous NF-B targets IL8 and TNF were determined with quantitative PCR (qPCR) in the absence (B) or presence (C) of TNF.
Statistical comparisons are relative to the negative control. (D) HEK293 cells were co-transfected with the indicated miRNA mimics and siRNAs.
si-p65-A and si-p65-B are two independent p65 siRNAs. Statistical comparison is relative to cells transfected with miR-517a/c + si-neg. (E)
Western blot analysis of nuclear and cytoplasmic protein extracts from HEK293 cells transfected with the indicated miRNAs. Tubulin and Lamin
A/C were cytoplasmic and nuclear loading controls, respectively. (F) DNA binding ELISA assay to quantify p65 activation in nuclear extracts from
HEK293 cells transfected with the indicated miRNAs. All values are means ± SD. n = 3. *P ≤0.05, **P ≤0.01. miRNAs, micro RNAs; NF-B, nuclear
factor kappa-B; siRNAs, small interfering RNAs; SD, standard deviation; TNF, tumor necrosis factor.
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Figure 5 TNIP1 is the direct functional target of miR-517a/c. (A) Western blot analysis of lysates from HEK293 cells transfected with the
indicated miRNAs. GAPDH was the loading control. (B and C) qPCR analysis of IL8 and TNF expression in HEK293 cells (B) transfected with two
independent siRNAs against TNIP1 or (C) co-transfected with the indicated miRNAs and plasmid cDNAs. TNIP1 cDNA construct contained the
complete coding sequence with a truncated 3’UTR. (D) Genome browser view of miR-517a/c binding site (red box) in TNIP1 3’UTR showing
relative conservation across species. Also indicated is the presence of SNP rs72558377 in the binding site (red arrow). (E) Predicted base pairing
between miR-517a and the TNIP1 binding site containing the major (C) and minor (T) alleles of rs72558377. ‘|’ and ‘:’ indicate Watson-Crick and
wobble base pairing, respectively.(D) Both SNP alleles of the miR-517a/c target site in TNIP1 were cloned into the 3’UTR of a firefly luciferase
reporter. The reporter also expressed Renilla luciferase from a separate promoter. The reporter was co-transfected with the indicated miRNAs in
HEK293 cells. Firefly luciferase activity was normalized to that of Renilla luciferase. Statistical comparisons are relative to negative control (miR-
neg). All values are means ± SD. B and C, n = 3. E, n = 4. *P ≤0.05, **P 0.01. miRNAs, micro RNAs; siRNAs, small interfering RNAs; SD, standard
deviation; TNIP1, tumor necrosis factor alpha-induced protein 3 interacting protein 1.
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Figure 6 miR-517a/c induce apoptosis in HEK293 and U-2 OS cells. (A) Microscope images of HEK293 and U-2 OS cells transfected with miR-
517a/c. (B) Caspase3/7 activity was measured in HEK293 and U-2 OS cells transfected with miR-517a/c with the Caspase-Glo 3/7 luminescence assay.
(C) Western blot analysis of whole cell protein extracts from HEK293 cells transfected with miR-517a/c. Cleavage of PARP is evident by the lower
molecular weight fragment and is indicative of caspase3 activity. HSP90 was the loading control. (D) Microscope images of HEK293 cells transfected
with TNIP1 siRNA. (E) Similar to (B) casapase 3/7 activity in HEK293 cells transfected with pooled siRNAs against TNIP1. (F) Western blot analysis of
whole cell protein extracts transfected with pooled TNIP1 siRNAs. All values are means ± SD. n = 3. *P ≤0.05, **P ≤0.01. miRNAs, micro RNAs; PARP,
poly(ADP-ribose) polymerase; siRNAs, small interfering RNAs; SD, standard deviation; TNIP1, tumor necrosis factor alpha-induced protein 3 interacting
protein 1.
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cells transfected with miR-517a/c using the Caspase-Glo
3/7 luminescence assay. miR-517a/c increased CASP-3/7
activity 16-fold in HEK-293 cells and 8-fold in U-2 OS
cells relative to the negative control (Figure 6B). To
confirm the assay results, we tested the effect of miR-
517a/c on the cleavage of poly (ADP-ribose) polymerase
1 (PARP1), an endogenous CASP3 target. miR-517a/c
induced cleavage of full length PARP1 while no cleaved
PARP1 was observed in lysates of control cells (Figure
6C). Together, these results suggested that miR-517a/c
induced apoptosis in HEK293 and U-2 OS cells.
Next, we tested if miR-517a/c induced apoptosis was a
result of TNIP1 knockdown. TNIP1 promotes cell survi-
val and is essential for development. Mice lacking
TNIP1 have extensive TNF induced apoptosis in the
liver and few are born live [30]. Similar to miR-517a/c,
siRNA mediated knockdown of TNIP1 increased cell
death in HEK 293 cells (Figure 6D). Also, TNIP1 knock-
down increased CASP-3/7 activity (Figure 6E) and clea-
vage of PARP1 (Figure 6F). Together, these results
suggested that knockdown of TNIP1 contributes to the
apoptosis inducing activity of miR-517a/c.
Finally, we questioned whether the apoptosis inducing
effects of miR-517a/c were specific to cancer-derived/
immortalized cell lines. We transfected primary
HUVECs with miR-517a/c and, similar to HEK293 and
U2-OS cells, we observed increased cell death and
CASP-3/7 activity (see Additional file 2, Figure S5).
Hence, these results suggest that miR-517a/c can induce
apoptosis in primary and immortalized cells.
Discussion
In this study, we identified 22 miRNAs that regulated basal
or TNF-induced NF-B signaling using high-throughput
cell-based screening. Some of these hits are known regula-
tors or direct targets of NF-B. miR-24, miR-125b and
miR-210 are direct NF-B targets and were hits in our
screen [31-33]. Further, miR-125b was recently shown to
promote NF-B signaling by targeting TNFAIP3 [16].
Likewise, miR-210 was recently shown to inhibit signaling
by targeting NF-ΚB1/p50 [34]. Both of these findings are
consistent with our screening data and suggest miR-125b
and miR-210 are feedback regulators of NF-B signaling.
Also, studies by Jiang et al. suggest miR-30e-3p promotes
NF-B signaling by targeting the inhibitor IB-a [35].
While miR-30e-3p did not meet the cutoff in our +TNF
screen (P = 0.05), the related miR-30a-3p was a hit (P =
0.02), activating reporter activity. In all, these results con-
firmed that our primary screen effectively identified
known miRNA regulators of NF-B signaling.
During the preparation of this study, to our knowledge
two other groups published screens investigating the role
of miRNAs in NF-B signaling [36,37]. A comparison of
the experimental methods is detailed in Additional file 1,
Table S4. The first by Lu et al. looked at the effects of
miRNAs on basal NF-B reporter activity (that is, non-sti-
mulated) [36]. They found miR-301a was the strongest
inducer (approximately 5-fold increase in reporter activity)
and that it functioned by targeting NFKB repressing factor
(NKRF). miR-301a was not a hit in our screen (P = 0.18;
average fold change = 2.3). However, the related family
members miR-130a and miR-130b (that is, with the same
seed regions as miR-301a and likely overlapping targets)
both increased basal reporter activity by 4.5-fold (P = 0.04)
and 3.6-fold (P = 0.06), respectively (see Additional file 1,
Table S2). Further, miR-130a was a hit in the +TNF screen
with a 3.8-fold increase (P = 0.02; Table 1). Hence, our
results are in agreement with the Lu et al. study suggesting
that the miR-301/miR-130 family positively regulates NF-
B signaling. However, none of the activators confirmed
in our secondary screen (miR-483, miR-517a and miR-
517c) were hits in the Lu et al. study.
In the second study by Keklikoglou et al., the authors
examined the effect of miRNAs on TNF-induced NF-B
reporter activity [37]. They identified 13 miRNA families
as hits (P < 0.2). Upon initial evaluation, none of these
were hits in our screen. We then relaxed our P-value
cutoff from 0.02 to 0.05 and three miRNA families over-
lapped between the screens: miR-27ab, let-7/miR-98 and
miR-500. Interestingly, members of the miR-181 family
consistently upregulated the reporter in the Keklikoglou et
al. study, while all four members downregulated reporter
activity in our study to varying degrees (see Additional file
1, Table S2). Our results are consistent with a recent study
by Sun et al. demonstrating miR-181b inhibition of NF-B
through importin-a3 [38]. Further, miR-517a/c were
identified as negative regulators in the Keklikoglou screen.
miR-517a/c were potent activators in our -TNF screen
and were not hits in our +TNF screen (Table 1). However,
as noted before, we did observe a slight decrease in repor-
ter activity by miR-517c in the secondary screen (Figure
1C). Interestingly, none of the validated hits from our
+TNF secondary screen (miR-210, miR-375 or miR-483)
were hits in the Keklikoglou et al. study.
We believe the differences in the screen results largely
stem from methodological and technical differences (see
Additional file 1, Table S4). All three studies used differ-
ent NF-B reporters that were transiently or stably
expressed in HEK293/293FT cells. A critical factor may
be the sensitivity and specificity of these reporters. Also,
the duration of transfection was 72 hours in our screen,
but 48 hours in the Lu and Keklikoglou screens. During
the optimization of our screen, we found that this
longer transfection period was necessary for the optimal
impact of our positive controls on reporter activity (data
not shown). However, the optimal transfection time
depends on several factors including the abundance and
half-life of the target proteins as well as the response
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kinetics of the reporter assay. In all, however, the differ-
ences between the screens are not unusual. Such discor-
dance is also found in large RNAi screens [39,40]. This
highlights the importance of replication studies and sug-
gests that follow-up of top hits from all screens is neces-
sary to understand fully the roles of diverse miRNAs in
NF-B signaling.
Determining the mechanism of miRNA action by find-
ing their functional targets is challenging. This problem is
two-fold. First, identify the targets, which can number in
the hundreds, and second, from these, identify the ones
mediating the effect of the miRNA. This can be limited by
a lack of preexisting knowledge of the pathway of interest.
Also, exhaustively testing the candidates can be unfeasible
(miRNA hits times dozens to hundreds of candidates). We
addressed this problem by integrating computational
predictions from TargetScan and data from our genome-
wide cDNA screen for regulators of NF-B signaling [20].
With this method, we derived high confidence candidate
targets for all the miRNAs with the exception of miR-
517a/c. This was likely because miR-517a/c had about
eight times fewer predicted targets than the other miRNAs
(see Additional file 1, Table S3). For future studies, the
target list from our analysis has to be validated experimen-
tally. A few high-throughput experimental methodologies
for evaluating miRNA targets have been successfully
implemented. These include high-throughput sequencing
of RNAs isolated by crosslinking immunoprecipitation
(HITS-CLIP), photoactivatable-ribonucleoside enhanced
crosslinking and immunoprecipitation (PAR-CLIP), ribo-
some profiling, and microarray analysis of cells or tissues
with perturbed miRNA states [41-44]. These datasets are
becoming available for more miRNAs and their integra-
tion into functional annotation pipelines, such as the one
in our study, will be highly informative in identifying func-
tional miRNA-mRNA interactions.
For follow up studies, we focused on the role of primate
specific miR-517a and miR-517c as potent inducers of NF-
B signaling. We identified TNIP1, an inhibitor of NF-B,
as a direct target gene. Interestingly, miR-517b was not a
hit in our screen despite extensive homology to miR-517a/
c (Figure 4A). Also, miR-517b did not phenocopy miR-
517a/c in secondary screens (Figure 3A) or knockdown
TNIP1 protein expression (Figure 5A). These differences
were likely due to a single nucleotide shift in the
miR-517b mature sequence relative to miR-517a/c (Figure
4A). According to TargetScan predictions [45], this shift
results in base-pairing between TNIP1 and nucleotides 2
to 7 of miR-517b as opposed to nucleotides 2 to 8 in miR-
517a/c-the latter resulting in a more favorable miRNA-tar-
get interaction. This result highlights the importance of
the miRNA seed in mediating miRNA-target interactions
and suggests caution in extrapolating the function of
individual miRNAs to their family members, particularly
when their seed regions differ. Interestingly, during the
preparation of this study we examined sequence reads of
the miR-517b locus from miRBase [46], the central reposi-
tory for miRNA sequences, and found a variant identical
to miR-517a. This suggests that the shifted variant is either
a result of read errors or a true 5’ isomiR-the likes of
which have been demonstrated in multiple species [47].
We informed the curators of miRBase, and the unshifted
sequence (identical to miR-517a) is the new reference for
miR-517b (now miR-517b-3p) as of miRBase v17.
While knockdown of TNIP1 was sufficient to induce
expression of TNF and IL8 as much as 18- and 56-fold,
respectively (Figure 5B), miR-517a/c were more potent
inducers (Figure 4B). Also, overexpression of TNIP1 did
not completely block miR-517a/c induced expression of
TNF and IL8. This suggests that the effect of miR-517a/c
on NF-B signaling may be mediated by other genes in
the pathway in addition to TNIP1. This is consistent with
numerous studies suggesting that miRNAs regulate
cellular pathways by targeting multiple components [48].
Further studies are needed to elucidate additional miR-
517a/c targets. The TNIP1 3’UTR harbors a functional
SNP in the miR-517a/c binding site. SNPs are the most
common form of human polymorphisms with millions
validated in the National Center for Biotechnology
Information (NCBI)’s dbSNP. Here, we show that the
minor allele of SNP rs72558377 (T) creates a G-U base
pair between miR-517a/c and TNIP1 that disrupts bind-
ing, resulting in reduced knockdown of TNIP1. This is
consistent with studies demonstrating the deleterious
effect of G-U base pairing between a miRNA’s seed and
target mRNA [49,50]. There are currently no reported
phenotypes associated with rs72558377, but future studies
may shed light on the potential consequence of this SNP
and the broader biological function of miR-517a/c.
An oncogenic role for miR-517a has been suggested in
liver and brain tumors [28,29]. Given miR-517a/c activated
NF-B signaling in our screen, this is consistent with the
well-established anti-apoptotic role of NF-B [51,52].
However, we found miR-517a/c induced apoptosis in the
immortalized cell line HEK293, in the osteosarcoma cell
line U-2 OS and in primary HUVECs. Corroborating our
results, a study by Yoshitomi et al. found miR-517a
induced apoptosis in the bladder cancer cell lines T24 and
BOY [53]. Also, interestingly, Na et al. recently found
miR-517a down-regulated in the placenta of patients with
complete hydatidiform moles-a condition characterized by
increased trophoblast proliferation [54]. Hence, our results
suggest that the knockdown of TNIP1 by miR-517a/c may
both activate NF-B signaling and repress its anti-apopto-
tic activity. Also, these conflicting functions of miR-517a/c
may reflect the complex role of NF-B in the regulation of
cell survival. In some cases, NF-B can promote apoptosis
in a context and cell type-specific manner [55]. Additional
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studies are needed to understand how survival signals
differ in various cell types in response to miR-517a/c and
the role NF-B may play in this process. As miR-517a/c
are suppressed in most cell/tissue types, their reported
activation by demethylating drugs, such as 5-aza-2′-deoxy-
cytidine (5-aza-dc) [56] may have therapeutic value in the
treatment of certain cancers.
Conclusions
This study provides a valuable resource for the functional
annotation of miRNAs in the NF-B pathway. Our data
suggest that miRNAs are common regulators. While
additional studies are needed to identify the functional
targets of these miRNAs, we provide a starting list of
likely candidates by integrating target predictions and
cDNA screening data. Lastly, we conclude that miR-
517a/c are pro-apoptotic and potent activators of NF-B
that function at least in part through TNIP1.
Methods
Tissue culture and cell maintenance
HEK293 andU-2 OS cells were purchased from American
Type Culture Collection (ATCC, Manassas, VA, USA).
Primary HUVEC cells (Lonza, Walkersville, MD, USA)
were a kind gift from Dr. Vladimir Muzykantov
(University of Pennsylvania) and were used no later than
passage 6. The NF-B-luc (HEK293) cell line was a gener-
ous gift from Dr. Sumit Chanda (Burnham Institute).
Briefly, HEK293 cells were transfected with 2 μg of a 5X
NF-B-luc luciferase reporter in a 100 mm dish and clonal
selection was carried out with neomycin. HEK293 and U-2
OS cells were maintained in growth media containing 10%
fetal bovine serum (FBS), 1X penicillin/streptomycin/glu-
tamine (Life Technologies, Grand Island, NY, USA) in (D)
MEM. HUVECs were maintained in growth media made
with the EGM-2 BulletKit (Lonza; CC-3162) according to
the manufacturer’s protocol. All cells were kept in a
humidified incubator at 37°C and 5% CO2.
siRNAs and miRNA
All Ambion miRNA mimics used in the primary screen
and follow-up studies as well as siRNAs against p65
(#216912 and #143124) were from Life Technologies.
siRNAs against TNIP1 (SI04315815 and SI04317341)
were from Qiagen (Valencia, CA, USA).
Primary screen
A miRNA mimic library (Ambion; Pre-miR library v 8.0)
was spotted at 1.6 pmol/well in a 384-well format. NF-B-
luc cells were reverse transfected with Lipofectamine2000
(Life Technologies). Briefly, 10 μL of OptiMEM (Life
Technologies) was added to each spotted well. A total of
10 μL of transfection reagent mix containing 1% Lipofecta-
mine2000 in OptiMEM was then added to each well and
incubated for 20 minutes. Cells were prepared in 2X
growth media ((D)MEM, 20% FBS, 2X L-glutamine (Life
Technologies)) at a final concentration of 1.5 × 105 cells/
mL. A total of 20 μL of cell suspension was added to each
well. Plates were maintained under normal growth condi-
tions for 72 hours. Stock TNF (Sigma, St. Louis, MO,
USA) solution was diluted in (D)MEM and 5 uL was
added to each well to a final concentration of 40 ng/mL.
Luciferase levels were quantified 8.5 hours later, using
BriteLite assay systems (Perkin Elmer, Shelton, CT, USA)
on an Envision Multilabel plate reader (Perkin Elmer) fol-
lowing the manufacturer’s protocols. Raw luminescence
values were log transformed and robust Z-scores were cal-
culated for each well using the following formula: Z-score
= (xi -med(x))/mad(x). Where xi is the luminescence value
for well i, med(x) is the median of the plate and mad(x) is
the median absolute deviation of the plate. P-values were
estimated with a Wilcoxon rank sum test (two-sided)
comparing each duplicate pair to the experiment wide
distribution.
Secondary screen
Secondary screen was performed as per the primary
screen in a 96-well format (final volume 100 μL). NF-
B-luc cells were co-transfected with the miRNA
mimics (50 nM final) and pGL4.74 Renilla construct
(Promega, San Luis Obispo, CA, USA; final 30 ng/well).
Following treatment with TNF (40 ng/mL-final), firefly
and Renilla luciferase levels were quantified using the
Dual-Glo Luciferase Assay System (Promega) according
to the manufacturer’s protocol.
Caspase-Glo assay
HEK293 and HUVEC cells were plated in a 96-well
plate at 5,000 cells/well in 100 μL of the respective
growth media with no antibiotics. The next day, cells
were transfected with miRNA mimics at a final concen-
tration of 50 nM with Lipofectamine RNAiMAX (Life
Technologies) according to the manufacturer’s protocol.
Caspase activity was measured 96 hours later with the
Caspase-Glo 3/7 Assay (Promega) according to the man-
ufacturer’s protocol.
Computational analysis for high-confidence miRNA targets
miRNA targets were predicted using Perl scripts from Tar-
getScanHuman (http://www.Targetscan.org) version 6.0 as
per the websites instructions [21,22]. Predictions were
made irrespective of target site or miRNA conservation.
The 328 miRNA sequences used as input for the program
are listed in Additional file 1, Table 1 and correspond to
the miRBase v 8.0 annotation used in the construction of
the library. For the cross-screen comparisons, the list of
modulators was derived from a previously described study
[20]. All subsequent analyses were done in R.
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Transfection and TNF stimulation of HEK293, U-2 OS and
HUVEC cells
HEK293 and U-2 OS cells were seeded in 6-well (for
protein) or 24-well (for RNA) plates at 1 × 105 and 2.5 ×
104 cells/well, respectively, in media containing 10% FBS
and 1X L-glutamine in OptiMEM/(D)MEM (1:1). HUVEC
cells were seeded in 60 mm dishes (for protein) or 24-well
plates (for RNA) at 1.6 × 105 and 4 × 104 cells/well respec-
tively, in HUVEC growth medium without antibiotics.
Cells were co-transfected the next day with plasmids and
miRNAs using Lipofectamine 2000 (Life Technologies)
according to the manufacturer’s protocol. RNAiMAX was
used for all other transfections according to the manufac-
turer’s protocol. miRNAs and siRNAs were transfected at
a final concentration of 50 nM each. Plasmids were trans-
fected at a final concentration of 125 ng/well (24-well
plate) or 500 ng/well (6-well plate). Mimic ‘miR-517a/c’
contained equal amounts of miR-517a and miR-517c. The
amount of nucleic acid was held constant across
conditions in every experiment by adding the respective
negative controls (negative control siRNAs/mimics or
empty vector). Cells were transfected for 72 hours (unless
otherwise stated in the text) and maintained under normal
growth conditions before harvesting for protein or RNA.
HEK293 cells were stimulated with TNF at a final concen-
tration of 40 ng/mL for 3 hours (unless otherwise indi-
cated) before processing for RNA.
Western Blot
Whole cell protein extracts were isolated from HEK293
cells with ice-cold RIPA buffer. Nuclear and cytoplasmic
extracts were isolated with the NE-PER Nuclear and
Cytoplasmic Extraction kit (Pierce, Rockford, IL, USA).
All extraction buffers were supplemented with a pro-
tease inhibitor cocktail (Complete; Roche, Indianapolis,
IN, USA). Protein concentrations were quantified with
the DC protein assay (BioRad, Hercules, CA, USA). A
total of 50μg (whole cell) or 10μg (nuclear/cytoplasmic
extracts) of protein was resolved on Tris-HCL SDS gels
(BioRad) and transferred to polyvinylidene difluoride
(PVDF) membranes. Membranes were blocked for 1
hour at room temperature in blocking solution (2.5%
milk, 0.5% Tween20, 1X Tris-buffered saline) followed
by a 1 hour incubation with the primary antibody in
blocking solution. Primary antibodies used were: anti-
p65 (4764S), anti-IB-a (4814S), anti-Lamin A/C (2032),
anti-PARP (9532S), anti-HSP-90 (4875; Cell Signaling
Technologies, Danvers, MA, USA), anti-Tubulin
(ab7291; Abcam, Cambridge, MA, USA), anti-TNIP1
(15104-1-AP; Proteintech Group, Chicago, IL, USA) and
anti-GAPDH (sc-25778; Santa Cruz Biotechnology,
Santa Cruz, CA, USA). Membranes were rinsed twice
each with TBS-0.1% tween and blocking solution then
probed with anti-rabbit immunoglobulin G (IgG)
horseradish peroxidase (HRP)-linked secondary antibody
(NA934-1ML; GE Healthcare, Mickleton, NJ, USA) for
30 minutes in blocking solution. Membranes were
rinsed 4 times for 15 minutes in TBS-0.1% tween solu-
tion followed by the application of enhanced chemilumi-
nescence (ECL) western blotting detection reagent (GE
Healthcare) and developed by standard autoradiograph
techniques.
p65 ELISA assay
p65 activation was measured in nuclear extracts of
HEK293 cells with a commercial DNA binding ELISA
kit (ActiveMotif (Carlsbad, CA, USA) TransAM NFB
p65 Chemi) according to the manufacturer’s protocol. A
total of 500 ng of protein was used for each assay.
Cloning of TNIP1 construct
Human full-length TNIP1 cDNA (BC012133; Thermo
Scientific, Waltham, MA, USA) was PCR amplified with
primer set 5’-GCATACTAGTAAGCTCCCCGTC-
CTCGGCCA-3’ and 5’- GCATCTCGAGAGCCTCT-
CATCCAGCTGAGGCTCT-3’ (Integrated DNA
Technologies, Coralville, IA, USA) and cloned into the
SpeI and XhoI restriction sites of pCMV-sport6 vector
(Invitrogen) using standard recombinant DNA techniques.
The resulting construct was verified by DNA sequencing.
Expression of TNIP1 from the construct was confirmed by
western blot.
Cloning of 3’UTR reporter constructs
Both strands of the respective target regions were synthe-
sized (Intergrated DNA Technologies) with overhangs for
ligation into the NheI and XhoI restriction sites of the
pmiRGlo Dual Luciferase vector (Promega). Complemen-
tary strands were annealed by mixing 50 μL of each 100
μM oligo (in 1x Tris-EDTA (TE)) with 100 μL of 2X
annealing buffer (100 mM NaCl in 1X TE) and placing in
a 99°C water bath for 2 minutes. The heat source was then
turned off and the samples were allowed to cool to room
temperature. Annealed oligos were then purified with the
Qiaquick Nucleotide removal kit (Qiagen). The resulting
double stranded approximately 46 bp DNA segment was
diluted (1:100) and cloned into the restriction sites of the
pmiRGlo vector using standard recombinant DNA techni-
ques. The resulting constructs were verified by DNA
sequencing. The oligos synthesized were as follows:








Olarerin-George et al. BMC Biology 2013, 11:19
http://www.biomedcentral.com/1741-7007/11/19
Page 14 of 16
RNA extraction and quantitative PCR
RNA was extracted from HEK293 cells in high-throughput
format with the Nucleospin 96 RNA kit (Macherey-Nagel,
Bethlehem, PA, USA) following the manufacturer’s proto-
col. For the TNF time-course experiment, RNA was
extracted with miRNeasy kit (Qiagen) following the manu-
facturer’s suggested protocol for total RNA isolation
(including small RNAs). cDNA was generated from
500 ng of RNA using the miScript Reverse Transcription
kit (Qiagen) and quantitative PCR was performed on the
7900HT Real-Time PCR System (Life Technologies) using
the Quantitect SYBR Green PCR kit (Qiagen) according to
the manufacturers’ protocols. The ΔΔCT method was
used for relative expression quantification using the RQ
manager software v2.4 (Life Technologies). 18S rRNA
(or RNU6B) was the endogenous reference for all mRNA
(or miRNA) quantification experiments. All primer sets
were purchased from Qiagen: TNF (QT01079561), IL8
(QT00000322), IL6 (QT00083720), TNIP1(QT00044072),
18S rRNA(QT00199367), miR-517a (MS00004459), miR-
517c (MS00009954), RNU6B (MS00029204).
Statistical analysis
All comparisons between group means were performed
with a two-sided heteroscedastic Student’s t-test.
Additional material
Additional file 1: Supplemental tables. Table S1. miRNA library
annotation; Table S2. Primary screen data; Table S3. Number of predicted
targets per miRNA hit; Table S4. Comparison of genome-wide miRNA
screens for regulators of NF-B.
Additional file 2: Supplemental figures. Figure S1. p65 siRNA
validation; Figure S2. Functional analysis of miR-517a/c in primary
HUVECs; Figure S3. TNIP1 overexpression in HEK293 cells; Figure S4. TNF
time course treatment in HEK293 cells; Figure S5. miR-517a/c-induced
apoptosis in HUVECs.
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